These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 30365140)

  • 1. Oncolytic cancer therapy with a vaccinia virus strain.
    Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B; Hu Z
    Oncol Rep; 2019 Jan; 41(1):686-692. PubMed ID: 30365140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9.
    Deng L; Fan J; Guo M; Huang B
    Cancer Lett; 2016 Mar; 372(2):251-7. PubMed ID: 26803055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.
    Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B
    Oncotarget; 2017 Jun; 8(25):40533-40543. PubMed ID: 28465492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic therapy with vaccinia virus carrying IL-24 for hepatocellular carcinoma.
    Deng L; Yang X; Ding Y; Fan J; Peng Y; Xu D; Huang B; Hu Z
    Virol J; 2022 Mar; 19(1):44. PubMed ID: 35292065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-24-Armed Oncolytic Vaccinia Virus Exerts Potent Antitumor Effects via Multiple Pathways in Colorectal Cancer.
    Deng L; Yang X; Fan J; Ding Y; Peng Y; Xu D; Huang B; Hu Z
    Oncol Res; 2021 Mar; 28(6):579-590. PubMed ID: 32641200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the replication characteristics of vaccinia virus strains Guang 9 and Tian Tan in vivo and in vitro.
    Zhu R; Liu Q; Huang W; Yu Y; Wang Y
    Arch Virol; 2014 Oct; 159(10):2587-96. PubMed ID: 24838849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.
    Chen NG; Yu YA; Zhang Q; Szalay AA
    J Transl Med; 2011 Sep; 9():164. PubMed ID: 21951588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatory effects of vaccinia virus VG9 and the STAT3 inhibitor Stattic on cancer therapy.
    Yang R; Wang L; Sheng J; Huang Q; Pan D; Xu Y; Yan J; Wang X; Dong Z; Yang M
    Arch Virol; 2019 Jul; 164(7):1805-1814. PubMed ID: 31087190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison on virulence and immunogenicity of two recombinant vaccinia vaccines, Tian Tan and Guang9 strains, expressing the HIV-1 envelope gene.
    Zhu R; Huang W; Wang W; Liu Q; Nie J; Meng S; Yu Y; Wang Y
    PLoS One; 2012; 7(11):e48343. PubMed ID: 23139778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
    Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH
    PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers.
    Haddad D; Chen N; Zhang Q; Chen CH; Yu YA; Gonzalez L; Aguilar J; Li P; Wong J; Szalay AA; Fong Y
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S665-74. PubMed ID: 22258815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent.
    Gentschev I; Stritzker J; Hofmann E; Weibel S; Yu YA; Chen N; Zhang Q; Bullerdiek J; Nolte I; Szalay AA
    Cancer Gene Ther; 2009 Apr; 16(4):320-8. PubMed ID: 18949014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-21 arming potentiates the anti-tumor activity of an oncolytic vaccinia virus in monotherapy and combination therapy.
    Chen T; Ding X; Liao Q; Gao N; Chen Y; Zhao C; Zhang X; Xu J
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33504576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68.
    Gentschev I; Donat U; Hofmann E; Weibel S; Adelfinger M; Raab V; Heisig M; Chen N; Yu YA; Stritzker J; Szalay AA
    J Biomed Biotechnol; 2010; 2010():489759. PubMed ID: 20379368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and evaluation of a new oncolytic vaccinia virus strain LIVP6.1.1 for canine cancer therapy.
    Gentschev I; Patil SS; Adelfinger M; Weibel S; Geissinger U; Frentzen A; Chen NG; Yu YA; Zhang Q; Ogilvie G; Szalay AA
    Bioengineered; 2013; 4(2):84-9. PubMed ID: 23093804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of oncolytic vaccinia virus for therapy of canine soft tissue sarcoma.
    Gentschev I; Adelfinger M; Josupeit R; Rudolph S; Ehrig K; Donat U; Weibel S; Chen NG; Yu YA; Zhang Q; Heisig M; Thamm D; Stritzker J; Macneill A; Szalay AA
    PLoS One; 2012; 7(5):e37239. PubMed ID: 22615950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68.
    Gentschev I; Müller M; Adelfinger M; Weibel S; Grummt F; Zimmermann M; Bitzer M; Heisig M; Zhang Q; Yu YA; Chen NG; Stritzker J; Lauer UM; Szalay AA
    PLoS One; 2011; 6(7):e22069. PubMed ID: 21779374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JNK-deficiency enhanced oncolytic vaccinia virus replication and blocked activation of double-stranded RNA-dependent protein kinase.
    Hu W; Hofstetter W; Guo W; Li H; Pataer A; Peng HH; Guo ZS; Bartlett DL; Lin A; Swisher SG; Fang B
    Cancer Gene Ther; 2008 Sep; 15(9):616-24. PubMed ID: 18535619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Tumor Specificity and Immunity of Thymidine Kinase-Deleted Vaccinia Virus Guang9 Strain.
    Ding Y; Fan J; Deng L; Peng Y; Zhou B; Huang B
    Onco Targets Ther; 2020; 13():7683-7697. PubMed ID: 32801778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Oncolytic Vaccinia Virus Armed with GM-CSF and IL-24 Double Genes for Cancer Targeted Therapy.
    Deng L; Yang X; Fan J; Ding Y; Peng Y; Xu D; Huang B; Hu Z
    Onco Targets Ther; 2020; 13():3535-3544. PubMed ID: 32425553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.